Insulin-like growth factor-I receptor, E-cadherin and αv integrin form a dynamic complex under the control of α-catenin

International Journal of Cancer

Volumn 122, Issue 3, 2008, Pages 572-582

  Canonici, Alexandra ^a   Steelant, Wim ^b   Rigot, Véronique ^a   Khomitch Baud, Alexandra ^c   Boutaghou Cherid, Hikma ^c   Bruyneel, Erik ^d   Van Roy, Frans ^e   Garrouste, Françoise ^a   Pommier, Gilbert ^a   André, Frédéric ^a,f  

^a AIX MARSEILLE UNIVERSITY   (France)

^b NEW MEXICO INSTITUTE OF MINING AND TECHNOLOGY   (United States)

^c Biovays   (France)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e GHENT UNIVERSITY   (Belgium)

^f CNRS   (France)

Author keywords

Adhesion; Colorectal cancer; Migration; Vitronectin

Indexed keywords

ALPHA CATENIN; CD51 ANTIGEN; CELL ADHESION MOLECULE; SOMATOMEDIN C RECEPTOR; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; COLORECTAL CANCER; COMPLEX FORMATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOCALIZATION; IMMUNOPRECIPITATION; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ALPHA CATENIN; CADHERINS; CELL ADHESION; CELL MOVEMENT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HT29 CELLS; HUMANS; IMMUNOPRECIPITATION; INTEGRIN ALPHAV; PHOSPHOPROTEINS; RECEPTOR, IGF TYPE 1; RNA, SMALL INTERFERING;

EID: 37349131288     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23164     Document Type: Article

References (49)

1. Eliceiri BP. Integrin and growth factor receptor crosstalk. Circ Res 2001;89:1104-10.
2. LeRoith D, Roberts C. The insulin-like growth factor system and cancer. Cancer Lett 2003;195:127-37.
3. Furstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol 2002;3:298-302.
4. Angst BD, Marcozzi C, Magee AI. The cadherin superfamily: diversity in form and function. J Cell Sci 2001;114:629-41.
5. Mareel M, Leroy A. Clinical, cellular, and molecular aspects of cancer. Physiol Rev 2002;83:337-76.
6. Bracke ME, Vyncke BM, Bruyneel EA, Vermeulen SJ, De Bruyne GK, Van Larebeke NA, Vleminckx K, Van Roy FM, Mareel MM. Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro. Br J Cancer 1993;68:282-9.
7. Hiscox S, Jiang WG. Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells. Biochem Biophys Res Commun 1999;261:406-11.
8. André F, Rigot V, Remacle-Bonnet M, Luis J, Pommier G, Marvaldi J. Protein kinases C-γ and -δ are involved in insulin-like growth factor I-induced migration of colonic epithelial cells. Gastroenterology 1999;116:64-77.
9. Morali O, Delmas V, Moore R, Jeanney C, Thiery J, Larue L. IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 2001;20:4942-50.
10. Mauro L, Salerno M, Morelli C, Boterberg T, Bracke ME, Surmacz E. Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progression. J Cell Physiol 2003;194:108-16.
11. Chen J, Wu A, Sun H, Drakas R, Garofalo C, Cascio S, Surmacz E, Baserga R. Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and β-catenin. J Biol Chem 2005;280:29912-20.
12. Humphries M, McEwan P, Barton S, Buckley P, Bella J, Mould A. Integrin structure: heady advances in ligand binding, but activation still makes the knees wobble. Trends Biochem Sci 2003;28:313-20.
13. Ridley A, Schwartz M, Burridge K, Firtel R, Ginsberg M, Borisy G, Parsons J, Horwitz A. Cell migration: integrating signals from front to back. Science 2003;302:1704-9.
14. Cooper CR, Chay CH, Pienta KJ. The role of α(v)β(3) in prostate cancer progression. Neoplasia 2002;4:191-4.
15. André F, Rigot V, Thimonier J, Montixi C, Parat F, Pommier G, Marvaldi J, Luis J. Integrins and E-cadherin cooperate with IGF-I to induce migration of epithelial colonic cells. Int J Cancer 1999;83: 497-505.
16. Clemmons D, Maile L. Integral membrane proteins that function coordinately with the insulin-like growth factor I receptor to regulate intracellular signaling. Endocrinology 2003;144:1664-70.
17. von Schlippe M, Marshall J, Perry P, Stone M, Zhu A, Hart I. Functional interaction between E-cadherin and αv-containing integrins in carcinoma cells. J Cell Sci 2000;113:425-37.
18. Avizienyte E, Wyke A, Jones R, McLean G, Westhoff M, Brunton V, Frame M. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol 2002;4:632-8.
19. Rigot V, Lehmann M, Andre F, Daemi N, Marvaldi J, Luis J. Integrin ligation and PKC activation are required for migration of colon carcinoma cells. J Cell Sci 1998;111:3119-27.
20. Vermeulen SJ, Nollet F, Teugels E, Vennekens KM, Malfait F, Philippe J, Speleman F, Bracke ME, van Roy FM, Mareel MM. The αE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells. Oncogene 1999;18:905-15.
21. Yatohgo T, Izumi M, Kashiwagi H, Hayashi M. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct Funct 1988;13:281-92.
22. Vermeulen SJ, Bruyneel EA, Bracke ME, De Bruyne GK, Vennekens KM, Vleminckx KL, Berx GJ, van Roy FM, Mareel MM. Transition from the noninvasive to the invasive phenotype and loss of α-catenin in human colon cancer cells. Cancer Res 1995;55:4722-8.
23. van Hengel J, Gohon L, Bruyneel E, Vermeulen S, Cornelissen M, Mareel M, van Roy F. Protein kinase C activation upregulates intercellular adhesion of α-catenin-negative human colon cancer cell variants via induction of desmosomes. J Cell Biol 1997;137:1103-16.
24. Steelant WF, Goeman JL, Philippe J, Oomen LC, Hilkens J, Krzewinski-Recchi MA, Huet G, Van der Eycken J, Delannoy P, Bruyneel EA, Mareel MM. Alkyl-lysophospholipid 1-O-octadecyl-2- O-methylglycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro. Int J Cancer 2001;92:527-36.
25. Kokura S, Yoshida N, Imamoto E, Ueda M, Ishikawa T, Uchiyama K, Kuchide M, Naito Y, Okanoue T, Yoshikawa T. Anoxia/reoxygenation down-regulates the expression of E-cadherin in human colon cancer cell lines. Cancer Lett 2004;211:79-87.
26. Luis J, Martin JM, el Battari A, Fantini J, Giannellini F, Marvaldi J, Pichon J. Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptors. Eur J Biochem 1987;167:391-6.
27. Boutaghou-Cherid H, Porcher C, Liberge M, Jule Y, Bunnett NW, Christen MO. Expression of the neurokinin type 1 receptor in the human colon. Auton Neurosci 2006;124:9-17.
28. Bracke M, Boterberg T, Bruyneel E, Mareel M. Collagen invasion assay. In: Brooks SA, Schumacher U, eds. Metastasis research protocols, vol. 2. Totowa NJ: Humana Press, 2001:81-9.
29. Gouranton E, Andre F. Interactions between insulin-like growth factor receptor, E-cadherin/catenin complex and integrins. Role in cell migration. Curr Top Biochem Res, in press.
30. André F, Janssens B, Bruyneel E, van Roy F, Gespach C, Mareel M, Bracke M. α-catenin is required for IGF-I-induced cellular migration but not invasion in human colonic cancer cells. Oncogene 2004;23:1177-86.
31. Goel H, Fornaro M, Mora L, Teider N, Rhim J, King M, Languino L. Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by β1 integrins. J Cell Biol 2004;166:407-18.
32. Wang JY, Gualco E, Peruzzi F, Sawaya BE, Passiatore G, Marcinkiewicz C, Staniszewska I, Ferrante P, Amini S, Khalili K, Reiss K. Interaction between serine phosphorylated IRS-1 and β1-integrin affects the stability of neuronal processes. J Neurosci Res 2007;85:2360-73.
33. Nejjari M, Berthet V, Rigot V, Laforest S, Jacquier MF, Seidah NG, Remy L, Bruyneel E, Scoazec JY, Marvaldi J, Luis J. Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model. Am J Pathol 2004;164:1925-33.
34. Comoglio P, Boccaccio C, Trusolino L. Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr Opin Cell Biol 2003;15:565-71.
35. Guvakova MA, Surmacz E. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp Cell Res 1997;231:149-62.
36. Mauro L, Bartucci M, Morelli C, Ando S, Surmacz E. IGF-I receptor-induced cell-cell adhesion of MCF-7 breast cancer cells requires the expression of junction protein ZO-1. J Biol Chem 2001;276:39892-7.
37. Kiely PA, O'Gorman D, Luong K, Ron D, O'Connor R. Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and β1 integrin to promote cell migration. Mol Cell Biol 2006;26:4041-51.
38. Kiely P, Leahy M, O'Gorman D, O'Connor R. RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251. J Biol Chem 2005;280:7624-33.
39. Howe A, Aplin A, Alahari S, Juliano R. Integrin signaling and cell growth control. Curr Opin Cell Biol 1998;10:220-31.
40. Reiss K, Wang JY, Romano G, Tu X, Peruzzi F, Baserga R. Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells. Oncogene 2001;20:490-500.
41. Goel H, Breen M, Zhang J, Das I, Aznavoorian-Cheshire S, Greenberg N, Elgavish A, Languino L. β1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts. Cancer Res 2005;65:6692-700.
42. Matsubara S, Osawa M. Expression of α-catenin in α-catenin-deficient cells increase resistance to sphingosine-induced apoptosis. J Cell Biol 2001;154:573-84.
43. Vasioukhin V, Bauer C, Degenstein L, Wise B, Fuchs E. Hyperproliferation and defects in epithelial polarity upon conditional ablation of α-catenin in skin. Cell 2001;104:605-17.
44. Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ. Deconstructing the cadherin-catenin-actin complex. Cell 2005;123:889-901.
45. Chattopadhyay N, Wang Z, Ashman L, Brady-Kalnay S, Kreidberg J. α3β1 integrin-CD151, a component of the cadherin-catenin complex, regulates PTPmu expression and cell-cell adhesion. J Cell Biol 2003;163:1351-62.
46. Hintermann E, Yang N, O'sullivan D, Higgins J, Quaranta V. Integrin α6β4-erbB2 complex inhibits haptotaxis by up-regulating E-cadherin cell-cell junctions in keratinocytes. J Biol Chem 2005;280:8004-15.
47. Liu D, el-Hariry I, Karayiannakis AJ, Wilding J, Chinery R, Kmiot W, McCrea PD, Gullick WJ, Pignatelli M. Phosphorylation of β-catenin and epidermal growth factor receptor by intestinal trefoil factor. Lab Invest 1997;77:557-63.
48. Schlaepfer D, Mitra S, Ilic D. Control of motile and invasive cell prenotypes by focal adhesion kinase. Biochim Biophys Acta 2004;1692:77-102.
49. Sekimoto H, Eipper-Mains J, Pond-Tor S, Boney CM. (α)v(β)3 integrins and Pyk2 mediate insulin-like growth factor I activation of Src and mitogen-activated protein kinase in 3T3-L1 cells. Mol Endocrinol 2005;19:1859-67.